Expert campus | Novel approaches in Drug development
Moderator:
- Till Schäberle – Professor, Department of Insect Biotechnology at University of Gießen & Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)
Speakers:
- Albina Poljak – Director Business Development, PhagoMed Biopharma GmbH
- Timothy Schulz-Utermoehl – Co-founder & Director, Pedanius Therapeutics
This content has been restricted to logged in users only. Please login to view this content.
- Niamh Máire Mohan – Pre-Clinical Technologist, Nuritas limited
This content has been restricted to logged in users only. Please login to view this content.
- Till Schäberle – Professor, Department of Insect Biotechnology at University of Gießen & Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)
This content has been restricted to logged in users only. Please login to view this content.
- Cesar de la Fuente – Machine Biology Group, University of Pennsylvania
This content has been restricted to logged in users only. Please login to view this content.
Play Video
This might also be of interest for you:
- News release, 16 July: Phagomed selected for EIT Gold Track program
- News release, 22 April: Nuritas Enters the Race to Find Therapeutic Peptides for the Treatment of COVID-19
- Article, 23 August 2019 about a joint venture between Nuritas and Stonehaven Incubate: AI to accelerate animal health ingredient discovery
- Learn more about AI-driven research for antibiotic discovery at De la Fuente Lab, University of Pennsylvania
- Learn more about the Department of Insect Biotechnology at University Gießen
- News release, 19 November 2019: A new antibiotic to combat drug-resistant bacteria
- Learn more about the RNAi-based approach of Pedanius Therapeutics to combat gram-negative bacterial infections